Identification of novel direct transcriptional targets of glucocorticoid receptor

Leukemia

Volumn 18, Issue 11, 2004, Pages 1850-1856

  U, M ^a   Shen, L ^a,b   Oshida, T ^c   Miyauchi, J ^d   Yamada, M ^a   Miyashita, T ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b SHANGHAI CHILDREN S MEDICAL CENTER   (China)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^d TOKYO DENTAL COLLEGE   (Japan)

Author keywords

ALL; DSCR1; FKBP51; Glucocorticoid; Granzyme A

Indexed keywords

ADENINE; CYCLOHEXIMIDE; CYTOSINE; DEXAMETHASONE; FK 506 BINDING PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GRANZYME A; GUANINE; ISOPROTEIN; NUCLEOTIDE; PROTEIN BCL 2; THYMINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; DRUG RECEPTOR BINDING; EXON; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; INTRON; LEUKEMIA; LEUKEMIA CELL LINE; LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 8844276831     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403516     Document Type: Article

References (36)

1. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002; 9 6-19.
2. Tissing WJ, Meijerink JP, den Boer ML, Pieters R. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003; 17: 17-25.
3. Riccardi C, Cifone MG, Migliorati G. Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: role of GITR and GILZ, two dexamethasone-induced genes. Cell Death Differ 1999; 6: 1182-1189.
4. Barker PE, Carroll AJ, Cooper MD. t(1;19)(q23;p13) in pre-B acute lymphocytic leukemia cell line 697. Cancer Genet Cytogenet 1987; 25: 379-380.
5. Yoshida N-L, Miyashita T, U M, Yamada M, Reed JC, Sugita Y et al. Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem Biophys Res Commun 2002; 293: 1254-1261.
6. Beresford PJ, Kam CM, Powers JC, Lieberman J. Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci USA 1997; 94: 9285-9290.
7. Shresta S, Graubert TA, Thomas DA, Raptis SZ, Ley TJ. Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity 1999; 10: 595-605.
8. Fuentes JJ, Pritchard MA, Estivill X. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 1997; 44: 358-361.
9. Baughman G, Wiederrecht GJ, Campbell NF, Martin MM, Bourgeois S. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol Cell Biol 1995; 15: 4395-4402.
10. Vega RB, Yang J, Rothermel BA, Bassel-Duby R, Williams RS. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem 2002; 277: 30401-30407.
11. Yamada M, Hirasawa A, Shiojima S, Tsujimoto G. Granzyme A mediates glucocorticoid-induced apoptosis in leukemia cells. FASEB J 2003; 17: 1712-1714.
12. Zhao Y, Tozawa Y, Iseki R, Mukai M, Iwata M. Calcineurin activation protects T cells from glucocorticoid-induced apoptosis. J Immunol 1995; 154: 6346-6354.
13. 2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J Biol Chem 1998; 273 28392-28398.
14. McEwan IJ, Wright AP, Gustafsson JA. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. BioEssays 1997; 19: 153-160.
15. Stöcklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996; 383: 726-728.
16. Imai Y, Matsushima Y, Sugimura T, Terada M. A simple and rapid method for generating a deletion by PCR. Nucleic Acids Res 1991; 19: 2785.
17. Pawlowski V, Revillion F, Hornez L, Peyrat JP. A real-time one-step reverse transcriptase-polymerase chain reaction method to quantify c-erbB-2 expression in human breast cancer. Cancer Detect Prev 2000; 24: 212-223.
18. Miesfeld R, Rusconi S, Godowski PJ, Maler BA, Okret S, Wikstrom AC et al. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 1986; 46: 389-399.
19. Shikama Y, Yamada M, Miyashita T. Caspase-8 and caspase-10 activate NF-κB through RIP, NIK and IKKα kinases. Eur J Immunol 2003; 33: 1998-2006.
20. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002; 16: 61 -71.
21. Planey SL, Abrams MT, Robertson NM, Litwack G. Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. Cancer Res 2003; 63: 172-178.
22. Tonko M, Ausserlechner MJ, Bernhard D, Helmberg A, Kofler R. Gene expression profiles of proliferating vs G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J 2001; 15: 693-699.
23. Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K et al. Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays. Oncogene 2002; 21: 1346-1358.
24. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN et al. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 2000; 87: E61-E68.
25. Wang Z, Malone MH, He H, McColl KS, Distelhorst CW. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 2003; 278: 23861-23867.
26. Kastan MB, Zhan Q, el Deiry WS, Carrier F, Jacks T, Walsh WV et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587-597.
27. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102: 849-862.
28. de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G et al. PML is a direct p53 target that modulates p53 effector functions. Mol Cell 2004; 13: 523-535.
29. Hubler TR, Denny WB, Valentine DL, Cheung-Flynn J, Smith DF, Scammell JG. The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 2003; 144: 2380-2387.
30. Strähle U, Klock G, Schütz G. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci USA 1987; 84 7871-7875.
31. Beato M, Chalepakis G, Schauer M, Slater EP. DNA regulatory elements for steroid hormones. J Steroid Biochem 1989; 32: 737-747.
32. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998; 93: 531-541.
33. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998; 17: 384-395.
34. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735-1738.
35. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 2000; 6: 1389-1399.
36. Villunger A, Michalak EM, Coultas L, Müllauer F, Böck G, Ausserlechner MJ et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003; 302: 1036-1038.